drugset / Trial / NCT01209533

Inhaled Iloprost in Mild Asthma

NCT01209533

Phase 0 Completed 24 enrolled Vanderbilt University Actelion · collab
Non-randomizedSingle-groupOpen-label

Summary

The purpose of the study is to determine if inhaled iloprost given four times daily can improve symptoms and lung function in adults with mild asthma.

Timeline

Start
2010-09
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Iloprost Other / unclassified 2.5 ug Inhaled
Subject Iloprost Other / unclassified 5 ug Inhaled

Indications